Alethio Therapeutics

Alethio develops targeted therapies to treat myeloproliferative neoplasms (MPNs), a group of chronic, incurable blood cancers.

Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series A
Initial Investment Year
2026
Alethio Hover Image